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Polymeric micro- and nanopartides are becoming a mainstay in
biomedicine, medical diagnostics, and therapeutics, where they
are used in implementing sensing mechanisms, as imaging contrast agents, and in drug delivery. Current approaches to the fabrication of such particles are typically finely tuned to specific

solidified. In general, the process kinetics in both strategies,
bottom-up and top-down, limit each approach to a narrow set
of materials, sizes, and structures. Individualized biomedical
applications require varying particle sizes and modalities, which,

monomer or polymer species, size ranges, and structures. We present a general scalable methodology for fabricating uniformly sized
spherical polymeric particles from a wide range of polymers produced with complex internal architectures and continuously tun-

ways for producing such diverse structures. For example, no
single nanoparticle size can reach the different areas of a tumor
and the surrounding stroma (26, 27), and particle size was found
to be crucial in cell adsorption and internalization (28). These

able diameters extending from the millimeter scale down to
50 nm. Controllable access to such a wide range of sizes enables

broad applications in cancer treatment immunology, and vaccines.
Our approach harnesses thermally induced, predictable fluid instabilities in composite core/cladding polymer fibers drawn from

a macroscopic scaled-up model called a "preform." Through a

stack-and-draw process, we produce fibers containing a multiplicity of identical cylindrical cores made of the polymers of choice

embedded in a polymer cladding. The instability leads to the

breakup of the initially intact cores, independent of the polymer
chemistry, into necklaces of spherical particles held in isolation
within the cladding matrix along the entire fiber length. We demonstrate here surface functionalization of the extracted particles
for biodetection through specific protein-protein interactions, vol-

umetric encapsulation of a biomaterial in spherical polymeric

shells, and the combination of both surface and volumetric func-

tionalities in the same particle. These particles used in distinct
modalities may be produced from the desired biocompatible polymer by changing only the geometry of the macroscopic preform

from which the fiber is drawn.

in turn, necessitate different materials-specific fabrication path-

findings suggest the benefit of particle fabrication processes that

are not constrained to narrow size spans. The widespread

adoption of polymeric particles in current and future biomedical

applications would be enhanced by addressing the challenge of
developing a scalable process that is sufficiently versatile to
bridge the micro- and nanoscales, is compatible with a variety of
polymers, and is capable of producing a multiplicity of particle
architectures optimized for specific applications.
Here, we describe a scalable top-down process that yields
uniformly sized spherical polymer particles with continuously
tunable diameters from micro- to nanoscales realized in prescribed structures without recourse to any premade device in
which the particles are formed. In lieu of prefabricated templates
(19) or microfluidic channels filled with coflowing fluids (25), we
rely here on thermal treatment of a core/cladding polymer fiber
to fluidize the core and controllably induce at the interfaces the

Plateau-Rayleigh capillary instability (PRI) (29-31), the natural
tendency of fluid cylinders to break up into spheres. The desired
polymer is placed in the core of a scaled-up macroscopic (centimeter-scale) "preform" in the solid state, which is then thermally

drawn into an extended fiber that defines the initial conditions

Medical drug
drugdelivery
deliveryapplications
(4) typically(4)make
typically
use ofinmicrodiagnostics
and nanomake use (1), of imaging micro- (2, and 3), nano- and
partides in two distinct modes: The surfaces may serve as loci for
chemical or biological interactions through surface functionali-

zation (5), or, alternatively, the volume may be used to carry
cargo (6, 7) for drug delivery and multidimensional imaging
modalities (8). Polymeric nanopartides in particular are steadily
gaining importance in medicine because of their long half-life in
the blood stream (9, 10) and the versatility by which their compo-

sition, size, shape, and physicochemical properties (11) may
be tuned via a variety of processing approaches. Recent medical
achievements based on the use of polymer particles in specific
applications include the targeted delivery of drugs and toxins using
surface-conjugated biodegradable polymer particles (12, 13), treat-

ment of antibiotic-resistant bacterial infections (14, 15), and induction of regulatory T cells for treatment of multiple sclerosis (16).

Current bottom-up synthetic approaches produce nanopartides that typically have considerable size dispersion, cannot reach

the microscale, and are sensitively tuned to specific chemical
building blocks (17). Top-down processes, on the other hand,

for the process (32, 33). The PRI results in an initially intact
cylindrical core breaking up into a necklace of uniformly sized
spherical particles held stationary in isolation following quenching

Significance
A scalable, chemistry-independent, fluid-instability-mediated
in-fiber route for fabricating uniformly sized spherical polymeric particles over a wide span of diameters is developed
targeting biomedical applications. Both surface functionalization of solid biocompatible polymer particles for proteinprotein interactions and volume encapsulation of a biological
material in spherical hollow polymer shells are confirmed, in
addition to combining both surface and volumetric functionalities in the same polymeric particle.
Author contributions: J J.K., R.C., and A.F.A. designed research; R.O., G.T., S.S., E.-H.B.,
X.L., S.G.J., Y.F., R.C., and A.F.A. performed research; J.J.K., R.O., X.L., S.G.J., Y.F., R.C., and

A.F.A. analyzed data; and J.J.K., R.O., X.L., S.G.J., Y.F., R.C., and A.F.A. wrote the paper.
The authors declare no conflict of interest.

such as emulsification (18), the use of templates (19), and

*This Direct Submission article had a prearranged editor.

microfluidics-based approaches (20-25), exploit polymers in a lowviscosity state or in solution and rely on prefabricated devices to

This article contains supporting information online at www.pnas.org/lookup/suppl/doi: 10.

impart form and size to the particles, which are subsequently
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in the solid cladding matrix along the whole fiber length, to be

released when needed using an appropriate solvent (34, 35).
Complex particle architectures are achieved by judicious design
of the core geometry at the macroscopic preform stage, which is,
in turn, inherited by the resulting particles. The scalability of the
process stems from stacking a high density of cores inside a single
fiber produced rapidly with extended lengths using the traditional

process of thermal drawing. Furthermore, we confirm that the

PRI-based process is "chemistry-independent" by using it to

produce particles from different polymers, some of which have
not been used heretofore in particle form despite their useful

biochemical, mechanical, and optical properties. Such salutary

features combined in this in-fiber fabrication approach (i.e., size
control, scalability, compositional, structural control) may enable
such polymeric particles to play an important role in biomedical
applications, such as recognition of specific cell types through
protein binding (36), separation of specific cells from a mixture
(37), and delivering biological materials or drugs (38). The large

quantities of particles produced may enable applications in

cosmetics (39) and emulsions used in coatings and paints,

whereas the size uniformity of polymeric particles is crucial in

ultrasound imaging (40). We establish critical steps toward

achieving these goals via three key demonstrations of biomedical
importance: (a) protein binding to the particle surfaces for biosensing, (b) quantitative control over differential surface protein

binding, and (c) encapsulation of a biological material in

a polymeric shell using collagen as a model material. These
demonstrations are carried out using the same biocompatible
polymer in two different particle structures, a solid spherical
particle for surface functionalization and a hollow spherical
particle for volumetric cargo encapsulation, produced by the infiber fabrication methodology. We also confirm that both surface
and volume functionalities may be combined in the same particle, a result that has wide implications for site-specific drug delivery (41).
Results

The in-fiber particle fabrication procedure may be divided into

three stages (35) (Fig. 'A)'(i) macroscopic preform preparation

Fig. 1. In-fiber emulsification as a route to producing spherical polymer
particles. (A) Preform-to-fiber approach. A centimeter-scale preform ( Upper
Leň) is drawn into a 1-mm-diameter fiber. The Roman numerals identify the
three fabrication stages outlined in the main text. (B) Optical transmission
micrograph of the fiber cross-section consisting of a 20-^m-diameter COP
core inside a PSU cladding. (C) Side views of a section of a fiber undergoing

thermal treatment at 321 °C showing the temporal evolution of the PRI
starting from the intact cylindrical COP core until it breaks up into a necklace

of particles embedded in the PSU cladding. (D) Size tunability of COP particles, released from the PSU cladding using DMAC, demonstrated in scanning electron micrographs. [Scale bar: D, successively reduced by a factor of
5 ( Upper to Lower)]. Particle diameters are ~53 nm, 10.6 ^m, 2.2 ^irn, 270 nm,

(stage I), (//) thermal fiber drawing (stage II), and (Hi) thermally and 61 nm. Details of the fabrication process are provided in Supporting

induced in-fiber emulsification via the PRI (stage III). TheInformation.

structure of the particle is determined in the preform fabrication
stage, whereas its size, proportional to the fiber core diameter, is

set in the fiber-drawing stage. The three processing stages are dimethylacetamide (DMAC)]. Note that the dissolved cladding
illustrated in Fig. L4, where a preform consisting of a 700-jim- polymer may be recycled from the solution and reused as a
diameter cylindrical cyclic olefin polymer (COP) (42) core sur- cladding for a new fiber. In Fig. ID, we show scanning electron
rounded by a 35-mm-diameter polysulfone (PSU) cladding micrographs of representative examples of particles with diam(stage I) is thermally drawn into hundreds of meters of a uniform eters extending three orders of magnitude from ~50 'im down to
1-mm-diameter fiber with a 20-nm-diameter core (stage II; Fig. ~50 nm. In general, this process yields a particle size distribution

IB). The drawn fiber is thermally treated under ambient having ~10% SD normalized with respect to the mean particle
conditions, thereby reducing materials viscosity and inducing size (details are provided in ref. 35).
the PRI (stage III), whose dynamics are shown in Fig. 1 C. The The scalability of particle production may be enhanced by

process is seeded by thermodynamic fluctuations that arise at the incorporating a large number of identical cores into the preform.

core/cladding interface upon heating. The classic Tomotika Two examples are shown in Fig. 2 to highlight this unique feamodel of the PRI predicts that the fluctuation wavelength with ture: a 14-core fiber (each with a 20-|im diameter; Fig. 2 A-D)
the shortest growth time dominates and its amplitude increases and a 1,000-core fiber (each with a 500-nm diameter; Fig. 2 Ewithout bound (34, 43), leading to the breakup of the COP core G), with both having a 1-mm o.d. Thermal treatment of either
into a necklace of uniformly sized spherical particles held in the fiber leads to the simultaneous breakup of all the cores via the
PSU cladding. The breakup wavelength is determined by the PRI into a 3D arrangement of particles held stationary in the

core diameter, interface surface energy, and materials viscosities cladding matrix. The limit on the particle production rate is thus
(34). The diameter of the produced particles may thus be con- set by the fiber-drawing speed, the fiber o.d., and the fiber-filling
tinuously tuned, for fixed core and cladding materials and pro- ratio (percentage of the fiber transverse cross-section occupied
cessing conditions, by changing the diameter of the fiber, which by the cores). Using currently available fiber fabrication techis readily achieved by adjusting the drawing parameters. This nology, our process may yield on the order of a few kilograms of
unique feature appropriated from the process of fiber drawing structured polymeric particles per day independent of the parallows for particle size tuning over several orders of magnitude in ticle size or structure.
linear dimension (35, 44-46). After breakup, we extract the COP
Our approach relies on placing the desired polymer in the core
particles by selective dissolution of the PSU cladding [using within a sacrificial thermoplastic polymer cladding chosen such
15550 I www.pnas.org/cgi/doi/10.1073/pnas.1310214110 Kaufman et al.
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the core and cladding polymers with a thermally compatible inorganic buffer layer added in the preform, in which case the core
and cladding may even be the same polymer. We realize this design here using PES in both the core and the cladding separated by

a layer of the thermally compatible chalcogenide glass, As2Se3
(49) (Fig. 3 B and C and Supporting Information). The PRI yields
particles having a core (polymer)/shell (glass) structure that are
released by dissolving the polymer cladding (using DMAC), and
the polymer particles are extracted by subsequent removal of the

shell (using NaOH in deionized water; Fig. 3D).

Fig. 2. Scalable in-fiber emulsification. Microscale (A~D ) and nanoscale ( E-G )

in-fiber emulsification. (A) Optical transmission micrograph of the crosssection of a 14-core fiber with 20-nm-diameter COP cores in a PSU cladding.
(Inset) Individual core cross-section. ( B ) Scanning electron micrograph of the
fiber side view showing the 14 intact COP cores after dissolving the PSU
cladding. The cores coalesce after removing the fiber from the solvent. (C)
Optical transmission micrograph of the fiber side view after thermally inducing the PRI, resulting in the cores breaking up into spherical particles
held stationary in the cladding matrix. (D) Optical transmission micrograph
of the released COP particles after dissolving the PSU cladding. ( E and F)
Scanning electron micrographs of 1,000 intact 500-nm-diameter COP cores

3

¡3

Sä

Ss

emerging from the fiber after dissolving the PSU cladding matrix. (G)
Scanning electron micrograph of the released COP particles. (Inset) Scanning
electron micrograph of a single particle. (Scale bar: 500 nm.)

that the pair of polymers may be thermally codrawn (32, 33). A
unique aspect of this physical process is that it depends on the
rheology of the materials and not on their chemistry, as long as
they are immiscible. This was confirmed by producing particles
from a wide range of polymers, including polystyrene (PS),
polycarbonate (PC), acrylonitrile butadiene styrene (ABS), polyetherimide (PEI), and polyethersulfone (PES) {Supporting Information). These polymers have very different biochemical,
mechanical, and optical characteristics, and some of them (e.g.,
COP and ABS) have yet to be produced in particle form. For
example, ABS at room temperature is a rigid polymer, but its
characteristics at room temperature do not come into play during breakup under thermal treatment. Although PS is extensively
used in biomedicine due to its low density (allowing for suspension of PS particles in aqueous solutions) and its chemical
inertness, COP maintains these characteristics with the additional benefits of its excellent protein adsorption characteristics
(47) and resistance to many more chemicals than PS, such as
acids, alkalis, and most organic polar solvents (e.g., acetone,
methanol, isopropyl alcohol) (48). Furthermore, the in-fiber
process allows for combining inorganic glasses and polymers in
a single-particle geometry (35).
Thus, although the particle formation process itself is independent of the chemistry of the core and cladding materials,
extracting the particles by selective dissolution of the cladding,
on the other hand, does indeed depend on the chemistry of the
fiber materials, which places restrictions on the potential polymeric core/cladding pairings. This constraint is lifted by separating

Fig. 3. Inorganic sacrificial buffer layer to facilitate particle extraction. (A)
Schematic of the fiber structure. (B and C) Optical reflection micrographs of
the fiber cross-section at two stages in the fabrication process (Supporting
Information). The core consists of a PES (P) cylinder surrounded by a layer of

an inorganic glass, As2Se3 (G). The core is embedded in a PES cladding matrix. (D) Time-lapse transmission optical micrographs of core (P)/shell (G)
particles placed in NaOH solution. The glass shell is dissolved, leaving behind
the polymer cores. (E) Theoretically predicted values for the figure-of-merit

ß based upon calculated breakup wavelengths Ai and A2 assuming equalamplitude perturbations (Supporting Information). Black continuous lines
are contours of fixed ß at the values of 0.2, 0.3, and 0.4. The dashed red line
corresponds to the experimental values of Dcore and Dshe N. Di and D2 are the
experimental values for Dcore and Dsheii/ respectively.

Kaufman et al. PNAS | September 24, 2013 | vol.110 | no. 39 | 15551
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Because the PRI develops at the two cylindrical interfaces, the
polymer-core/glass-buffer inner interface and the glass-buffer/
polymer-cladding outer interface (Fig. 3/4), the buffer thickness
must be chosen to ensure the formation of the core/shell structure. The instability wavelengths at these interfaces (X' and A2,
respectively) will generally be different. To assess whether the
chosen physical and geometric parameters yield a core/shell
structure, we adopt a figure-of-merit ß = AÀ/À, where AÀ = À2~ X'

and À = Small values of ß (i.e., X'~Xi) indicate that the

breakup produces the target core/shell geometry, whereas large
values of ß indicate that multiple polymer cores may form within

the glass shell. Using a recently developed theoretical model

based on linear stability analysis of the PRI in multilayer cylindrical structures (50-52), we calculate ß for different ratios of
core and shell diameters ( Dcore and Aheib respectively) and viscosities (ßcore and /¿shell' respectively) assuming that the average
initial perturbation amplitudes at the two interfaces are equal
(Fig. 3 E). This model reveals a wide range of parameters that yield

removed from the fiber PSU cladding, with antibodies conjugated with fluorophores (FAs) through adsorption, we directly
monitor optically the presence of bound proteins using two
readily distinguishable FAs: yellow-fluorescing FAI [Cy3-conjugated anti-rabbit antibodies produced in goat (gAr); Fig. 4 A] and
red-fluorescing FA2 [Alexa Fluor-647-conjugated anti-mouse
antibodies produced in goat (gAm); Fig. 4 B] (details are provided in Supporting Information). We next verified that the particle-bound proteins retain their native conformation through
optical detection of specific protein-protein interactions. We
coated the particles with mouse serum proteins and monitored
the fluorescence emitted by two FAs incubated with the particles,

one that recognizes mouse serum proteins (FA2, gAm antibodies; Fig. AD) compared with one that does not (FAI, gAr
antibodies; Fig. 4 C). Lack of fluorescence from FAI indicates

that mouse serum proteins remain uniformly bound to the particles in their native conformation, thereby preventing FAI from
binding directly to the particles. Moreover, protein binding may
be promoted through adding a positive charge to the hydrophobic

the target structure (taken to occur when ß < 0.4), including our
case of Dsheu «2.5Dcore. These results may be generalized to sys-

polymer particle surface by coating it with poly-L-lysine, a positively

tems comprising three different fluids (50), corresponding to multiple emulsions, a feature that we exploit below for encapsulation.

charged synthetic amino acid chain. This enhancement was confirmed by detecting stronger fluorescence from bound antibodies

A further degree of freedom that may be accessed by the infiber approach is the particle internal structure, which follows
that of the constructed macroscopic preform. Along these lines,

(compare the panels in Fig. 4 A and E) and also by observing
Förster resonant energy transfer (FRET) between two tandem
layers of particle-bound FAs (56, 57) from FAI to FA3 (Alexa
Fluor-647-conjugated anti-goat antibodies produced in donkey).

we have produced polymer core/shell particles (COP core and
PC shell) and bicompartmentalized polymer Janus particles
(PES and PEI hemispheres) (Supporting Information). Applying
our general fabrication strategy using different preform structures but the same biocompatible polymer (COP), we produce
two distinct particle structures tuned to two different classes of
applications. The first class consists of solid particles that we use

for demonstrating surface binding of protein and fluorescent
antibodies (FAs), a necessary step for biosensing; furthermore,
we verify controllable protein coating of the COP particles while
maintaining biological specificity. Using the same fabrication
procedure applied to a hollow-core fiber design, a second class of
particles is developed for encapsulation of selected materials inside a COP shell. We demonstrate this feature using collagen as a
model biological material, motivated by recent work demonstrating
the utility of collagen nanoparticles in skin tissue engineering (53),
bone regeneration (54), and treatment of bacterial infection (55).
We first demonstrate that the surfaces of the polymer particles

produced by the fluid instability-based process are amenable to
protein binding without pretreatment, and are thus suitable for

biosensing applications. By coating solid COP microparticles,

Antibodies F A3 recognize FAI and fluorescence from FAI
overlaps with the FA3 excitation band, thereby allowing for

FRET transfer (Fig. 4 E). We further verified that protein binding
is independent of particle diameter down to 500-nm diameters by
incubating 500-nm-diameter COP particles (Figs. 2 G and 4 F) with

FA4 (Alexa Fluor-488-conjugated gAm antibodies).
In addition to binding proteins uniformly to the polymer
particles, we obtained clear evidence for quantitative control

over the relative composition of the immobilized proteins using
different mixtures of cofilin and BSA as examples. We confirmed

that the relative composition of the particle-bound proteins

matches that of the mixtures used in solution, first by dissociation via boiling in a denaturing buffer and quantification of the

recovered proteins by electrophoresis in SDS Polyacrylamide
gels stained to identify BSA and cofilin. Second, we monitored
the amount of particle-bound cofilin directly by incubation with
specific FAs and measuring the fluorescence (Supporting Information). These results thus confirm that the particles can be
coated with a controlled amount of a protein that can be retrieved for subsequent characterization and quantification.

Fig. 4. Quantitative assessment of preferential protein coating
to polymer particles. (A and B) COP particles coated with FA1 (gAr)
or FA2 (gAm) yield yellow or red fluorescence when excited at 561
nm or 647 nm, respectively. Here, Aex is the excitation wavelength,

Aem is the emission wavelength, and green and red arrows correspond to the excitation with Àex = 561 nm and Aex = 647 nm,
respectively. (C and D) COP particles coated with mouse serum
(MS) yield red fluorescence with MS-specific FA2 (gAm) and none
with nonspecific FA1 (gAr). (E ) COP particles after treatment with

poly-L-lysine are coated with FA1 and then FA3 [anti-goat anti-

bodies produced in donkey (dAg), which recognize FA1]. Both
antibodies independently produce fluorescence upon excitation.
When FA1 is excited (at Xex = 561 nm) and the red fluorescence of
FA3 at Aem = 675 nm is monitored, we observe evidence for FRET
transfer from FA1 to FA3. (F, i) Differential interference contrast

(DIC) micrograph of a COP nanopartide (diameter of ~500 nm;
Fig. 26). FL, fluorescence. ( F , //) Native autofluorescence of the
COP particle under short-wavelength (405 nm) excitation. (F, /'//)
Fluorescence micrograph of the COP particle after coating with

FA4. (F, iv) Combined DIC and fluorescence image of the FA4coated COP nanopartide. (Scale bars: 500 nm.)

15552 I www.pnas.org/cgi/doi/10.1073/pnas.1310214110 Kaufman et al.

This content downloaded from 132.170.192.79 on Thu, 13 Dec 2018 14:22:32 UTC
All use subject to https://about.jstor.org/terms

Fig. 5. Microencapsulation of biological materials in polymer shells. (>4) Schematic of the steps for producing collagen-filled COP microcapsules. (Inset)
Hollow-fiber core lined with COP after dissolving the PSU cladding at the fiber tip. Optical transmission micrograph of the side view of the fiber before ( B ) and

after (C) being filled with collagen (slightly doped with a dye for visualization). (D) Encapsulated collagen particles (COP shell) held in the PSU cladding. (£)
Collagen/COP microcapsules released from the cladding. (Scale bars: B-E, 200 um.) (F) Collagen recovered after dissolving the COP shell. (6) A confocal
fluorescence micrograph of a collagen-filled microparticle with surface-bound FAs. (H) An overlay of a bright-field confocal micrograph on the fluorescence
image from 6. (Scale bars: 20 um.) P1f COP; P2f PSU.

Finally, we demonstrate a unique feature of our polymer
particle fabrication strategy that highlights its versatility with
respect to structural design. By modifying the macroscopic pre-

form structure, we produce a unique particle geometry that
enables us to establish microencapsulation of biological materials inside a polymeric shell of the same polymer used in the solid
particles used above in the protein-binding experiments. We use
collagen as the encapsulant, which may be useful for cosmetics
and dental applications (58, 59) and serves as a model for other
potential biological materials or drugs. Like many biological
materials, collagen is a globular solution lacking uniform fluid
consistency, and is thus incompatible with fiber drawing and
traditional microfluidics-based multiple-emulsion approaches.
We obviate this limitation by injecting the desired encapsulant
inside a drawn hollow fiber in which a COP layer lines the PSU
cladding (Fig. 5A and Supporting Information). We inject collagen into the 50-^m-diameter hollow core (Fig. 5 C) and thermally
induce the PRI, which results in the core breaking up into
a necklace of collagen-filled COP microcapsules (Fig. 5 D) held
stationary in the PSU cladding, which are then released using
DMAC (Fig. 5 E). We confirm that the microcapsules contain
protein by dissolving the COP shell (Fig. 5 F) and then using
a Coomassie Brilliant Blue dye Bradford protein-binding assay
(60) with the recovered cargo (Supporting Information).
The two modalities discussed thus far, surface functionalization and volume encapsulation, are combined in Fig. 5 G and H,
where we demonstrate surface binding of FA4 to collagen-filled
COP microcapsules. In comparison to current encapsulation
approaches that usually target biodegradable polymeric shells
(61, 62), our approach enables encapsulation with a wider range
of polymers, in addition to access to a broad range of sizes.
Discussion

We anticipate that by embedding multiple hollow cores

3

will produce a polymeric particle that encapsulates these agents in

isolated enclaves such that the encapsulants do not come into

i§

contact at any point during the process. Consequently, each particle may be considered a multicompartment microreactor that
produces localized chemical interactions using prescribed ratios of
reactants upon delivery of the cargo.
Such size-, material-, and structure-tunable polymeric particles
fabricated using the scalable, in-fiber, fluid instability-mediated
process are thus compatible with protein binding and biosensing
through protein-protein interactions. We expect that this meth-

¡I

odology will have broad applications in developing diagnostic

tools and cell-specific targeting of biomaterials. In addition, optical, magnetic, and potentially plasmonic functionalities may be
embedded within each particle through impregnation of the fiber
core at the preform level with appropriate dopants. An important

goal is to extend our methodology to polymers that may be

processed at lower temperatures to reduce damage or modification
to encapsulated or impregnated biological materials, thereby paving the way to therapeutic applications in drug delivery. Combining
our results on the precise structuring of multimaterial particles
using this in-fiber approach (35) with the biomedical capabilities
described here paves the way for the digital design of a unique class

of nanoengineered theranostic tools (63), where the chemical,
hydroscopic, optical, and biomedical properties are all tuned simultaneously within each structured particle through judicious
design of the macroscopic preform from which the fiber is drawn.
Materials and Methods
All the steps and details of the fiber fabrication, particle production, and
extraction are provided in Supporting Information. Additionally, we give the
details of surface functionalization and fluorescence measurements. Further

data on quantifying protein attachment to the particle surfaces is provided.
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